<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190327043125N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-06-08</date_registration>
      <primary_sponsor>Services Hospital Lahore</primary_sponsor>
      <public_title>EFFECTS OF SPINAL MANIPULATION ON THORACIC SPINAL PAIN</public_title>
      <acronym></acronym>
      <scientific_title>EFFECTS OF SPINAL MANIPULATION  VERSUS ROUTINE PHYSICAL THERAPY ON THORACIC SPINAL PAIN;A RANDOMIZED CONTROLLED TRIAL</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2640-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/39552</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization:  

Subjects suitable for inclusion will be randomly allocated into two groups; group A/ Experimental group and group B/ control group using coin toss method and allocation sequence will be concealed through  sealed envelopes.  

Concealment of allocation:

 	Allocation concealment will be achieved with sequentially numbered, opaque, sealed, envelopes (SNOSE). SNOSE will be used according to guidelines of Doig and Simpson (25). 
An independent researcher with no clinical involvement in the trial will make the concealed envelopes. 100 Envelopes will be made. Half envelops will contain folded papers with Treatment A written on them and the remaining half will contain folded papers with Treatment B written on them. A carbon paper will be inserted in each envelop with carbon side facing the paper so the allocation sequence, patient name, date of birth of participant and other information can be transferred onto allocation paper inside the envelope. 
A piece of tin foil is also inserted into envelop so the treatment card cannot be read against light. Envelops will be sealed and signed by the maker. A unique randomized number will be allocated to these envelops and shuffled vigorously. Then the envelops will be arranged sequentially and handed over to another independent researcher. 
Assessor will pretest the participant and if eligible envelope will be allocated to subject. Therapist will record the information on the envelope and open it afterwards to maintain the concealment. Assessor will record the post treatment findings and another independent analyst will analyze the data. 
This allocation of concealment will ensure the unpredictability of treatment allocation by investigators and patients, Blinding description: In these patients assessor will be blinded to allocation of treatment groups in this study. Patient will be blinded to treatment allocation as treatment will be given in separate rooms for each group. Therapist who is not blinded will not take the outcome measurements.</study_design>
      <phase>1</phase>
      <hc_freetext>Thoracic Spinal Pain effecting Quality of Life.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Subjects in experimental group will be managed with spinal manipulative therapy (a single attempt of  high-velocity low-amplitude thrust in prone position) &amp; ergonomic advice.The manipulation technique will be considered successful if an auditory or palpable release  is perceived by the therapist  and if an improved movement of that joint will be noted on post manipulative motion palpation besides the decrease in pain on visual Analogue Scale. Intervention 2: Control group:Subjects in the control group will be managed with routine physiotherapy (therapeutic  exercises of thoracic spinal muscles with three sets of 10 repetitions with the rest period of 30seconds between the sets) and  ergonomic advice.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is depends upon the results</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Ashfaq Ahmed</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1-Km Raiwind Road, Lahore</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 42 111 865 865</telephone>
        <email>ashfaq.ahmad@uipt.uol.edu.pk</email>
        <affiliation>The  University of Lahore</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Muhammad Sharif Waqas</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>jail road lahore</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 42 99205517</telephone>
        <email>waqasphysio@gmail.com</email>
        <affiliation>services Hospital Lahore</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Only patients who will receive a diagnosis of thoracic spine pain from the researcher will be accepted into the study.
Diagnosis will be made by questioning and examining the subject .•
Age between 40 and 60 years
Midline back pain
Mobility deficit in thoracic range of motion
Pain with compression into spine extension
Patients without any known cause of TSP</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patient with neurological signs &amp; symptoms
Osteoporosis
Severe spinal deformity
Any systemic disease e.g. cardiovascular or neurological etc
Traumatic history and any other red flags of spinal pain</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.6</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Pain in thoracic spine</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Subjects in experimental group will be managed with spinal manipulative therapy (a single attempt of  high-velocity low-amplitude thrust in prone position) &amp; ergonomic advice.The manipulation technique will be considered successful if an auditory or palpable release  is perceived by the therapist  and if an improved movement of that joint will be noted on post manipulative motion palpation besides the decrease in pain on visual Analogue Scale</i_keyword>
      <i_keyword>Control group:Subjects in the control group will be managed with routine physiotherapy (therapeutic  exercises of thoracic spinal muscles with three sets of 10 repetitions with the rest period of 30seconds between the sets) and  ergonomic advice.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Thoracic spine pain intesity. Timepoint: before and after treatment session and 8 &amp; 12 weeks after treatment. Method of measurement: visual analogue scale to measure pain.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Chest expansion. Timepoint: before and after intervention and 8, 12 weeks after intervention. Method of measurement: measuring tape.</sec_outcome>
      <sec_outcome>Range of motion. Timepoint: before and after intervention and 8, 12 weeks after intervention. Method of measurement: goniometer.</sec_outcome>
      <sec_outcome>Quality of Life. Timepoint: before and after intervention and 8, 12 weeks after intervention. Method of measurement: Quality of Life questionnaire.</sec_outcome>
      <sec_outcome>Blood pressure. Timepoint: before and after intervention and 8, 12 weeks after intervention. Method of measurement: digital sphygmomanometer.</sec_outcome>
      <sec_outcome>Heart rate. Timepoint: before and after intervention and 8, 12 weeks after intervention. Method of measurement: pulse oximeter.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Services Hospital Lahore</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-09-20</approval_date>
        <contact_name>Ethical committee/Institutional Review Board,The University of Lahore</contact_name>
        <contact_address>1-Km raiwin Road Lahore Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
